CatLane
- 10x Genomics (NASDAQ:TXG) filed two lawsuits in opposition to Illumina (NASDAQ:ILMN) within the District Courtroom of Delaware on Tuesday, alleging that the latter has infringed on its patents associated to a gene sequencing expertise, Reuters reported.
- In a row over ILMN’s genomics
